This Week in Sleep Medicine: February 12, 2019
While You Were Sleeping: What Sleep Technologists Need to Know This Week
Your media watchdog for headlines and trends
relevant to sleep technology and patient education.
Pre-clinical Trial on Cannabis Active Ingredients Offers Encouraging Results for Insomnia
February 4, 2019
From the article: “Tel Aviv, Israel-based Kanabo Research presented the results of its pre-clinical trial, which the company says brings it a step closer to providing a safe remedy for insomnia and other sleep disorders, without the risk of dependency or the possibility of an overdose. …This in vivo study evaluated the efficacy of varying compositions of active ingredients in cannabis to induce sleep in comparison to Diazepam, the active ingredient in Valium.”
Takeaway: It's difficult to convince cannabis enthusiasts that there are risks that come with using this substance, including drug dependence/addiction/habituation. It's good to see these potential adverse side effects taken seriously in research.
HEALTH LITERACY WATCH
Care About Research? Urge New Congress to Support Sleep & Sleep Disorders Today
February 7, 2019
From the blog post: “Friends in the U.S., if you care about narcolepsy research (or any other area of sleep and sleep disorders research), you can play an important role in ensuring that this research is supported by our federal government. While private fundraising for research is wonderful and important too, private fundraising cannot replace the need for federal funding. These two sources work together, but one cannot magically replace the need for the other. This is why advocacy is an important part of the solution.”